Publication | Open Access

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

Bone DiseaseZoledronic AcidBreast OncologyOncologyBone HealthCancer ManagementBreast CancerBig 01–04Breast SurgeryAdjuvant TherapyMedicineOrthopaedic SurgeryCancer Research